Synapse - Mark Kris

Search Within

Mark Kris

Results (873)

Molecular biomarkers of disease outcomes and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers

Journal Article

Choudhury, N. J.; Marra, A.; Sui, J. S. Y.; Flynn, J.; Yang, S. R.; Falcon, C. J.; Selenica, P.; Schoenfeld, A. J.; Rekhtman, N.; Gomez, D.; more...
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non–small cell lung cancer

Journal Article

Rusch, V. W.; Nicholas, A.; Patterson, G. A.; Waqar, S. N.; Toloza, E. M.; Haura, E. B.; Raz, D. J.; Reckamp, K. L.; Merritt, R. E.; Owen, D. H.; more...
Journal of Thoracic and Cardiovascular Surgery (2023)

Fulltext@MSK | Save

Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancer

Journal Article

Wang, S.; Rong, R.; Yang, D. M.; Fujimoto, J.; Bishop, J. A.; Yan, S.; Cai, L.; Behrens, C.; Berry, L. D.; Wilhelm, C.; more...
Journal of Clinical Investigation (2023)

Fulltext@MSK | Save

Phase II randomized study comparing proton craniospinal irradiation with photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis

Meeting Abstract

Yang, J. T.; Wijetunga, N. A.; Pentsova, E.; Wolden, S. L.; Young, R. J.; Correa, D.; Zhang, Z.; Zheng, J.; Warner, A. B.; Yu, H. A.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Clinicopathologic and mutational landscape of BRAF(V600E)-mutant non-small cell lung carcinoma

Meeting Abstract

Sui, J. S. Y.; Ladanyi, M.; Rudin, C. M.; Drilon, A. E.; Riely, G. J.; Kris, M. G.; Offin, M.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

LCMC LEADER neoadjuvant screening trial: LCMC4 evaluation of actionable drivers in early-stage lung cancers

Meeting Abstract

Sepesi, B.; Jones, D. R.; Meyers, B. F.; Chaft, J. E.; Sholl, L. M.; Shyr, Y.; Kelly, K.; Lin, J.; Bunn, P. A.; Minna, J. D.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Minimal residual disease (MRD) detection by ctDNA in relation to radiographic disease progression in patients with stage I-III non-small cell lung cancer (NSCLC) treated with definitive radiation therapy

Meeting Abstract

Lebow, E. S.; Murciano-Goroff, Y. R.; Jee, J.; Kalashnikova, E.; Feeney, J.; Sethi, H.; Aleshin, A.; Kris, M. G.; Chaft, J. E.; Rudin, C. M.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Outcomes of single-agent PD-(L)-1 versus combination with chemotherapy in patients with PD-L1-high (≥ 50%) lung cancer

Meeting Abstract

Elkrief, A.; Machado Alessi, J. V.; Ricciuti, B.; Rizvi, H.; Preeshagul, I. R.; Egger, J. V.; Chaft, J. E.; Rudin, C. M.; Riely, G. J.; Kris, M. G.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Clinical outcomes of immune checkpoint inhibitors in HER2-amplified non-small cell lung cancers

Meeting Abstract

DeMatteo, R.; Goldman, D. A.; Lin, S. T.; Buonocore, D. J.; Gao, J.; Chang, J. C.; Rekhtman, N.; Offin, M.; Yu, H. A.; Isbell, J. M.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Identification of pretreatment genomic biomarkers and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers

Meeting Abstract

Choudhury, N. J.; Marra, A.; Yang, S. R.; Falcon, C. J.; Heller, G.; Kris, M. G.; Reis-Filho, J. S.; Riely, G. J.; Yu, H. A.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save